Patent details

300959 Product Name: tildrakizumab

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300959
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2059534
Status:
SPC granted but not yet in force
Application number:
300959
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/1/18/1323
Marketing Authorization Type:
EEA
Marketing Authorization Date:
19/09/2018
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
05/12/2018
First Marketing Authorization date:
19/09/2018
Grant date:
15/01/2019
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
10/12/2018
SPC/SPC Extension Expiration Date:
20/02/2033
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
06/02/2023
 
 

 

Name:
Merck Sharp & Dohme LLC
Address:
126 East Lincoln Ave. P.O. Box 2000, 07065, Rahway, New Jersey , United States of America (US)

Historical Applicant/holder

From:
05/12/2018
To:
06/02/2023

 

Name:
Merck Sharp & Dohme Corp.
Address:
126 East Lincoln Avenue, 07065-0907, Rahway, New Jersey, United States of America (US)

Agent

Name:
ir. F.A. Geurts c.s.
From:
05/12/2018
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
07/23
Publication date:
15/02/2023
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
SPC
Journal edition number:
03/19
Publication date:
16/01/2019
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
SPC
Journal edition number:
51/18
Publication date:
12/12/2018
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Merge
Deed Number:
RC202300306A
Date Registered:
06/02/2023
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Merck Sharp & Dohme LLC
Address:
126 East Lincoln Ave. P.O. Box 2000, 07065, Rahway, New Jersey , United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
29/02/2028
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
15/01/2019 Outgoing Correspondence Decision grant 1 PDF /0/2/5/9/4/0800349520/docs/300959_1_outgoingcorrespondence20190116025207392.pdf
15/01/2019 SPC Documents Certificate SPC 1 PDF /0/2/5/9/4/0800349520/docs/300959_4_supplprotectioncertificate20190116025207478.pdf
10/12/2018 Outgoing Correspondence Confirmation receipt request 1 PDF /0/2/5/9/4/0800349520/docs/300959_2_244147l174.pdf
05/12/2018 Application Form First filed application form 3 PDF /0/2/5/9/4/0800349520/docs/300959_0_applicationform20181210111917971.pdf
05/12/2018 SPC Documents Annex SPC 1 PDF /0/2/5/9/4/0800349520/docs/300959_3_supplprotectioncertificate20210115035404017.pdf
05/12/2018 SPC Documents SPC Documents 13 PDF /0/2/5/9/4/0800349520/docs/300959_5_supplprotectioncertificate20181210111918430.pdf
05/12/2018 SPC Documents Marketing Authorization SPC 3 PDF /0/2/5/9/4/0800349520/docs/300959_6_supplprotectioncertificate20181210111918342.pdf